For YEARS, The Lack of Reliable Early Testing for Lyme Disease has left patients in limbo. What information Goes Undeted in Its earls, chances of Developing Chronic Complies – Including Persistment Fatigue, join Pain, and Neurology Issues – RISE DRAMATIOLLY.
Despite Growing Awareness, Existing Diagnostics Oft Fall Short, Especially in Identifying Lyme Soon after a tick bite.
Now, Encouraging Progress Is on the Horizon. Researchers at Actions Diagnostics Have Unveiled Lymeseek, an Ai-Powered Blood Test That Coup Mark a Turning Point in Early Detection.
With Over 90% Sensitive and Specificity, The Test Promisses to Correctly Identify Lyme Infection in 9 Out of 10 Patients –SpeCially in Its Earliest Stages.
Lowering Risk of Chronic Lyme
Lymeseek Lowrs HER Team Identified 10 Key Antigens and Combined them INTO A Single Test Panel-Far Simpler Than The Multi-Test Structure of the Traditional Method.
But the Real Breakthrough? Machine Learning. After Analyzing Blood Samples from 123 Lyme Patiences and 197 Uninfected Individuals, The Researchers Trained An ALGORITHM to Recography Individual Immune Patterns.
In Trials, the Test Correctly Flagged Over 90% of Early Lyme Cases, Compared to Just 27% Using The Convenderal Method. Furthermore, It’s Affordable and Runs on Standard Lab Equipment, Whiche Course Accessate Its Adoption on RELESD.
Such a Significant Increase in Accuracy Couelf Make a HUGE Difference to Patives at Earlier Stages of Lyme Disease, when the Inference is the Most Effectively Treated.
Aces Hopes to make the Test Commerlyly Available by the End of 2026, Potentially Transforming The Landscape of Lyme Diagnosis and Care.
Source: Association for Diagnostics & Laboratory Medicine (ADLM)
Click here to learn more about this test: Aces Diagnostics
